These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 29686025)
1. Shorter Intensive Care Unit Stays? The Majority of Post-Intravenous tPA (Tissue-Type Plasminogen Activator) Symptomatic Hemorrhages Occur Within 12 Hours of Treatment. Chang A; Llinas EJ; Chen K; Llinas RH; Marsh EB Stroke; 2018 Jun; 49(6):1521-1524. PubMed ID: 29686025 [TBL] [Abstract][Full Text] [Related]
2. Risk of Intracranial Hemorrhage Following Intravenous tPA (Tissue-Type Plasminogen Activator) for Acute Stroke Is Low in Children. Amlie-Lefond C; Shaw DWW; Cooper A; Wainwright MS; Kirton A; Felling RJ; Abraham MG; Mackay MT; Dowling MM; Torres M; Rivkin MJ; Grabowski EF; Lee S; Kurz JE; McMillan HJ; Barry D; Lee-Eng J; Ichord RN Stroke; 2020 Feb; 51(2):542-548. PubMed ID: 31842706 [TBL] [Abstract][Full Text] [Related]
3. Serum creatinine may indicate risk of symptomatic intracranial hemorrhage after intravenous tissue plasminogen activator (IV tPA). Marsh EB; Gottesman RF; Hillis AE; Urrutia VC; Llinas RH Medicine (Baltimore); 2013 Nov; 92(6):317-323. PubMed ID: 24145699 [TBL] [Abstract][Full Text] [Related]
4. Predictors of symptomatic intracranial haemorrhage in patients with an ischaemic stroke with neurological deterioration after intravenous thrombolysis. James B; Chang AD; McTaggart RA; Hemendinger M; Mac Grory B; Cutting SM; Burton TM; Reznik ME; Thompson B; Wendell L; Mahta A; Siket M; Madsen TE; Sheth KN; Nouh A; Furie KL; Jayaraman MV; Khatri P; Yaghi S J Neurol Neurosurg Psychiatry; 2018 Aug; 89(8):866-869. PubMed ID: 29487169 [TBL] [Abstract][Full Text] [Related]
5. Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator. Xian Y; Liang L; Smith EE; Schwamm LH; Reeves MJ; Olson DM; Hernandez AF; Fonarow GC; Peterson ED JAMA; 2012 Jun; 307(24):2600-8. PubMed ID: 22735429 [TBL] [Abstract][Full Text] [Related]
6. Rate of Symptomatic Intracerebral Hemorrhage Related to Intravenous tPA Administered Over Telestroke Within 4.5-Hour Window. Al Kasab S; Orabi MY; Harvey JB; Turner N; Aysse P; Debenham E; Holmstedt CA Telemed J E Health; 2018 Oct; 24(10):749-752. PubMed ID: 29369743 [TBL] [Abstract][Full Text] [Related]
7. Race/Ethnic differences in the risk of hemorrhagic complications among patients with ischemic stroke receiving thrombolytic therapy. Mehta RH; Cox M; Smith EE; Xian Y; Bhatt DL; Fonarow GC; Peterson ED; Stroke; 2014 Aug; 45(8):2263-9. PubMed ID: 25070958 [TBL] [Abstract][Full Text] [Related]
8. Causes, Predictors, and Timing of Early Neurological Deterioration and Symptomatic Intracranial Hemorrhage After Administration of IV tPA. Shah K; Clark A; Desai SM; Jadhav AP Neurocrit Care; 2022 Feb; 36(1):123-129. PubMed ID: 34228264 [TBL] [Abstract][Full Text] [Related]
9. Safety of Intravenous Thrombolysis among Stroke Patients Taking New Oral Anticoagulants--Case Series and Systematic Review of Reported Cases. Shahjouei S; Tsivgoulis G; Bavarsad Shahripour R; Jones GM; Alexandrov AV; Zand R J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2685-93. PubMed ID: 26542821 [TBL] [Abstract][Full Text] [Related]